Search Form
First, enter a politician or zip code
Now, choose a category

Key Votes

HB 1001 - Expanding Bioscience Research Funding - Key Vote

Colorado Key Votes

Thomas Massey, Jr. voted Yea (Passage) on this Legislation.

Read statements Thomas Massey, Jr. made in this general time period.

Stages

Family

Issues

Stage Details

Legislation - Signed (Executive) -

Title: Expanding Bioscience Research Funding

Legislation - Conference Report Adopted (Senate) (25-9) -
Legislation - Conference Report Adopted (House) (53-10) -
Legislation - Nonconcurrence Vote Passed (House) (60-3) -
Legislation - Bill Passed With Amendment (Senate) (26-9) - (Key vote)

Title: Expanding Bioscience Research Funding

Vote Smart's Synopsis:

Vote to pass a bill that expands state funding of bioscience research and allows early-stage bioscience companies to receive state government grants.

Highlights:
- Limits individual grants to $150,000 per early-stage bioscience research project, and limits the total amount of grant money an early-stage bioscience research company may receive to $250,000 (Sec. 1). - Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to offices of technology transfer for projects that focus on life sciences, engineering, material science, computer sciences, photonics, or nanotechnology (Sec. 1). - Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to early-stage bioscience companies that have licensed a technology from an in-state research institution or an office of technology transfer for the purpose of promoting the commercialization of therapeutic or diagnostic instruments to improve human health, bioscience technologies to improve agriculture, or biofuels (Sec. 1). - Limits eligibility for early-stage bioscience research grants to companies that have received less than $25 million in funds from grants and third-party investors, employs fewer than 20 individuals, and has its headquarters located in Colorado (Sec. 1). - Transfers $4.5 million from the Limited Gaming Fund to the Bioscience Discovery Evaluation Cash Fund for fiscal year 2008-2009, and $5.5 million for fiscal years 2009-2010, 2010-2011, and 2011-2012 (Sec. 2). - Appropriates $5.5 million from the General Fund to the Bioscience Discovery Evaluation Cash Fund beginning in fiscal year 2008-2009 (Sec. 3).
Note:

NOTE: THIS VOTE RECONSIDERS A PREVIOUS VOTE.

Legislation - Bill Passed With Amendment (Senate) (32-1) -
Legislation - Bill Passed (House) (52-13) - (Key vote)

Title: Expanding Bioscience Research Funding

Vote Smart's Synopsis:

Vote to pass a bill that expands state funding of bioscience research and allows early-stage bioscience companies to receive state government grants.

Highlights:
- Limits individual grants to $150,000 per early-stage bioscience research project, and limits the total amount of grant money an early-stage bioscience research company may receive to $250,000 (Sec. 1). - Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to offices of technology transfer for projects that focus on life sciences, engineering, material science, computer sciences, photonics, or nanotechnology (Sec. 1). - Requires at least 30 percent of the Bioscience Discovery Evaluation Cash Fund be used to provide grants to early-stage bioscience companies that have licensed a technology from an in-state research institution for the purpose of promoting the commercialization of therapeutic or diagnostic instruments to improve human health, bioscience technologies to improve agriculture, or biofuels (Sec. 1). - Limits eligibility for early-stage bioscience research grants to companies that have received less than $25 million in funds from grants and third-party investors, employs fewer than 20 individuals, and has its headquarters located in Colorado (Sec. 1). - Transfers $4.5 million from the Limited Gaming Fund to the Bioscience Discovery Evaluation Cash Fund for fiscal year 2008-2009, and $5.5 million for fiscal years 2009-2010, 2010-2011, and 2011-2012 (Sec. 2). - Appropriates $5.5 million from the General Fund to the Bioscience Discovery Evaluation Cash Fund beginning in fiscal year 2008-2009 (Sec. 3).
Legislation - Introduced (House) -

Title: Expanding Bioscience Research Funding

Sponsors

  • Bob L. Bacon (CO - D) (Out Of Office)
  • Cheri E. Jahn (CO - D) (Out Of Office)
  • Dianne I. Primavera (CO - D) (Out Of Office)
  • James L. 'Jim' Riesberg (CO - D) (Out Of Office)
  • Chris Romer (CO - D) (Out Of Office)
  • Brandon C. Shaffer (CO - D) (Out Of Office)
  • Sue Windels (CO - D) (Out Of Office)

Co-sponsors

  • Alice J. Borodkin (CO - D) (Out Of Office)
  • Betty Boyd (CO - D) (Out Of Office)
  • Bernie Buescher (CO - D) (Out Of Office)
  • Dorothy B. Butcher (CO - D) (Out Of Office)
  • Morgan L. Carroll (CO - D) (Out Of Office)
  • Edward Casso (CO - D) (Out Of Office)
  • K. Jerry Frangas (CO - D) (Out Of Office)
  • Dan Gibbs (CO - D) (Out Of Office)
  • Kenneth Marshall 'Ken' Gordon (CO - D) (Out Of Office)
  • Peter C. Groff (CO - D) (Out Of Office)
  • Mary A. Hodge (CO - D) (Out Of Office)
  • James 'Jim' Isgar (CO - D) (Out Of Office)
  • Steve Johnson (CO - R) (Out Of Office)
  • John M. Kefalas (CO - D) (Out Of Office)
  • Andrew 'Andy' Kerr (CO - D) (Out Of Office)
  • James E. 'Jim' Kerr (CO - R) (Out Of Office)
  • Mike Kopp (CO - R) (Out Of Office)
  • Alice D. Madden (CO - D) (Out Of Office)
  • Don Marostica (CO - R) (Out Of Office)
  • Thomas W. 'Tom' Massey Jr. (CO - R) (Out Of Office)
  • Liane 'Buffie' McFadyen (CO - D) (Out Of Office)
  • Karen Middleton (CO - D) (Out Of Office)
  • John P. Morse (CO - D) (Out Of Office)
  • Joe Rice (CO - D) (Out Of Office)
  • Andrew Romanoff (CO - D) (Out Of Office)
  • Raymond J. 'Ray' Rose (CO - R) (Out Of Office)
  • Christine Scanlan (CO - D) (Out Of Office)
  • Susan K. Shepherd (CO - D) (Out Of Office)
  • Nancy Spence (CO - R) (Out Of Office)
  • Abel J. Tapia (CO - D) (Out Of Office)
  • Nancy Janann Todd (CO - D) (Out Of Office)
  • Ron D. Tupa (CO - D) (Out Of Office)
  • Albert C. 'Al' White (CO - R) (Out Of Office)
  • Suzanne S. Williams (CO - D) (Out Of Office)
  • John P. Witwer (CO - R) (Out Of Office)
Skip to top
Back to top